Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebo-controlled trial
If significant weight loss is your medical priority and your budget allows it tirzepatide is worth the cost
The timeframe for GLP-1 medications to 'kick in' varies depending on what therapeutic effect you're measuring and which specific medication you're taking
Here, we focused primarily on the acute mitochondrial impact of 5FU, and although we arrived at the combination of 5FU and mitochondrial inhibitors (more specifically, 5FU and metformin) somewhat serendipitously, we have now generated evidence to support the use of 5FU and metformin combinations not only in patients with resistant or relapsed disease as previously suggested by others, but also in treatment-naive, first-line chemotherapy settings
Building these habits for 11 months instead of 3 months sets you up much better for long term maintenance when you eventually reduce or stop the medication
Standards of Care in DiabetesGLP-1 Therapies